BethDianeKirkpatrickMD

Infectious Disease • Burlington, VT

Associate Professor, Medicine, University of Vermont College of Medicine

Join to view full profile

Are you Dr. Kirkpatrick?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
111 Colchester Ave
Fletcher Allen Health Care
Burlington, VT 05401
Phone+1 802-847-4594

Summary

Dr. Beth Kirkpatrick, MD is an infectious disease specialist in Burlington, Vermont. She is currently licensed to practice medicine in Vermont and Maryland. She is affiliated with University of Vermont Medical Center and is an Associate Professor at University of Vermont College of Medicine.

Education & Training

Johns Hopkins UniversityFellowship, Infectious Disease, 1996 - 1999
University of RochesterResidency, Internal Medicine, 1992 - 1996
Albany Medical CollegeClass of 1992

Certifications & Licensure

VT State Medical License 1999 - 2026
MD State Medical License 1996 - 2000
American Board of Internal Medicine Infectious Disease

Clinical Trials

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus Start of enrollment: 2009 Jul 01
Completed
Phase 1
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Start of enrollment: 2010 Jan 01
Unknown status
Phase 1
Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine Start of enrollment: 2010 Apr 01
Completed
Phase 1
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh Start of enrollment: 2011 May 01
Completed
Phase 3
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults Start of enrollment: 2013 Nov 01
Completed
Phase 1
Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh Start of enrollment: 2016 Mar 01
Completed
Phase 2
Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant Start of enrollment: 2019 Mar 19
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Associations between Histo-Blood Group Antigen Status in Mother-Infant Dyads and Infant Oral Rotavirus Vaccine Immunogenicity in rural Zimbabwe.
Joshua Pun, Ceri Evans, Bernard Chasekwa, James A Church, Ethan Gough
The Journal of Infectious Diseases. 2024-10-01
1 citations
Differences in Rotavirus Shedding and Duration by Infant Oral Rotavirus Vaccination Status in Dhaka, Bangladesh, 2011-2014.
Jenna Ciszewski, Mami Taniuchi, Benjamin Lee, E Ross Colgate, James A Platts-Mills
The Journal of Infectious Diseases. 2024-07-25
Infant Non-Secretor Histoblood Group Antigen Phenotype Reduces Susceptibility to Both Symptomatic and Asymptomatic Rotavirus Infection.
Benjamin Lee, Md Abdul Kader, Masud Alam, Dorothy M Dickson, Patrick Harvey
Pathogens. 2024-03-04

Press Mentions

Colchester's Vernal Biosciences Manufactures the mRNA That’s Revolutionizing MedicineAugust 25th, 2021
Sorely Needed Dengue Vaccine Gets a Boost from Immune ProfilingMay 26th, 2021
Dengue Immune Function Discovery Could Benefit Much-Needed Vaccine DevelopmentMay 24th, 2021
Join now to see all

Grant Support

Vermont Cobre: Project 2: Innate Immune Responses To Cryptosporidium ParvumNational Center For Research Resources2006–2011
Clinical Trial: Phase I Evaluation Of A Live Attenuated Den4 VaccineNational Center For Research Resources2010
Campylobacter Jejuni Challenge: Assessment Of Homologous ProtectionNational Center For Research Resources2010
Campylobactor Jejuni Challenge Model Development: Dose-Ranging StudyNational Center For Research Resources2007–2010
Gamma-Delta T Cells And CryptosporidiosisNational Institute Of Allergy And Infectious Diseases2004–2008